Smith & Nephew plc buy melinda
Start price
05.04.18
/
50%
€14.42
Target price
20.04.18
€14.84
Performance (%)
3.17%
End price
20.04.18
€14.87
Summary
This prediction ended on 20.04.18 with a price of €14.87. With a performance of 3.17%, the BUY prediction by melinda for Smith & Nephew plc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Smith & Nephew plc | -2.560% | -2.560% | -23.612% | -36.591% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread Smith & Nephew plc diskutieren
SektorAusrüstung, Versorgung und medizinische Verteilung Agenda 05/04 Finale Dividendenzahlung
Smith und Nephew berufen Namal Nawana CEO
Namal Nawana
Smith and Nephew, das globale Medizintechnikunternehmen, hat die Ernennung von Namal Nawana zum CEO bekannt gegeben.
Er tritt der Gesellschaft bei und wird am 7. Mai 2018 in den Verwaltungsrat berufen.
Stopped prediction by melinda for Smith & Nephew plc
Smith & Nephew plc
Start price
Target price
Perf. (%)
€7.19
10.07.10
10.07.10
€11.00
10.01.11
10.01.11
21.43%
10.01.11
10.01.11
